Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jing-Jin Electric Technologies
688280
5
Hangzhou Anysoft Information Technology
300571
US OptionsDetailed Quotes
AZN250502C89000
- 0.00
- 0.000.00%
15min DelayTrading Apr 29 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest89.00Strike Price0.00Turnover0.00%IV23.56%PremiumMay 2, 2025Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma194.68Leverage Ratio--Theta--Rho--Eff Leverage--Vega
AstraZeneca Newsroom
TD Cowen Maintains AstraZeneca(AZN.US) With Buy Rating
AstraZeneca (AZN) Receives a Hold From Jefferies
UBS Remains a Buy on AstraZeneca (AZN)
Analysts' Top Healthcare Picks: Bicara Therapeutics Inc. (BCAX), AstraZeneca (AZN)
Research Alert: Core Eps Beat Partly Helped By Tax Adjustment, Full Year Guidance Reiterated
HSBC Maintains AstraZeneca(AZN.US) With Buy Rating, Raises Target Price to $79
J.P. Morgan Reaffirms Their Buy Rating on AstraZeneca (AZN)
Goldman Sachs Remains a Buy on AstraZeneca (AZN)
BNP Paribas Starts Astrazeneca at Outperform Rating, $75 Price Target
AstraZeneca (AZN) Receives a Buy From UBS
Goldman Sachs Maintains AstraZeneca(AZN.US) With Buy Rating, Raises Target Price to $196.51
Goldman Sachs Sticks to Its Buy Rating for AstraZeneca (AZN)
Barclays Sticks to Its Buy Rating for AstraZeneca (AZN)
AstraZeneca (AZN) Gets a Hold From Deutsche Bank
Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Roche Holding AG (OtherRHHVF) and AstraZeneca (AZN)
Bernstein Sticks to Their Buy Rating for AstraZeneca (AZN)
AstraZeneca's Promising Pipeline and Strategic Positioning in Lung Cancer Treatment Earns Buy Rating
AstraZeneca (AZN) Receives a Buy From UBS
AstraZeneca (AZN) Receives a Buy From J.P. Morgan
Goldman Sachs Maintains AstraZeneca(AZN.US) With Buy Rating, Raises Target Price to $98
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now